Christy Shaffer Net Worth

The estimated Net Worth of Christy L Shaffer is at least $5.59 Thousand dollars as of 15 August 2017. Christy Shaffer owns over 1,100 units of Clearside Biomedical stock worth over $5,588 and over the last 3 years he sold CLSD stock worth over $0. In addition, he makes $0 as Chairman of the Board at Clearside Biomedical.

Christy Shaffer CLSD stock SEC Form 4 insider trading

Christy has made over 3 trades of the Clearside Biomedical stock since 2017, according to the Form 4 filled with the SEC. Most recently he bought 1,100 units of CLSD stock worth $7,700 on 15 August 2017.

The largest trade he’s ever made was buying 2,200 units of Clearside Biomedical stock on 20 March 2017 worth over $15,180. On average, Christy trades about 440 units every 15 days since 2017. As of 15 August 2017 he still owns at least 4,400 units of Clearside Biomedical stock.

You can see the complete history of Christy Shaffer stock trades at the bottom of the page.

Christy Shaffer biography

Dr. Christy L. Shaffer, Ph.D., is the Chairman of the Board of Clearside Biomedical, Inc. Since August 2015, Dr. Shaffer has served as a Venture Partner with Hatteras Venture Partners, an investment firm, and as Managing Director of Hatteras Discovery, which invests in early-stage companies in the life sciences industry sector. From 1995 to March 2010, Dr. Shaffer served in increasing leadership positions at Inspire Pharmaceuticals, a publicly held biopharmaceutical company, beginning as the company’s first full-time employee and Director of Clinical Operations and eventually being appointed as Chief Executive Officer and a director of the company in 1999, as its President in 2005 and a member of its Development Committee in 2009. Prior to Inspire, she was a clinical research scientist, international project leader and Associate Director of Pulmonary and Critical Care Medicine at Burroughs Wellcome Co. Dr. Shaffer currently serves as a board member of the Chordoma Foundation and has served in leadership roles on several non-profit boards, including as chair of the Morehead Planetarium and Science Center’s advisory board, on the Board of Trustees for the Cystic Fibrosis Foundation, and as chair of the board of CFF Therapeutic, Inc. Dr. Shaffer currently serves on the board of G1 Therapeutics, Inc., a publicly traded biopharmaceutical company. Dr. Shaffer is a receptor pharmacologist by training, earning her Ph.D. in Pharmacology from the University of Tennessee’s Health Science Center in Memphis, Tennessee. She completed post-doctoral training at The Chicago Medical School as well as the University of North Carolina at Chapel Hill.

How old is Christy Shaffer?

Christy Shaffer is 60, he’s been the Chairman of the Board of Clearside Biomedical since 2012. There are 2 older and 5 younger executives at Clearside Biomedical. The oldest executive at Clearside Biomedical, Inc. is George Lasezkay, 67, who is the Interim Chief Executive Officer, Director.

What’s Christy Shaffer’s mailing address?

Christy’s mailing address filed with the SEC is 900 North Point Pkwy # 200, Alpharetta, GA 30005, USA.

Insider trading at Clearside Biomedical

Over the last 3 years, insiders at Clearside Biomedical have traded over $8,510,421 worth of Clearside Biomedical stock and bought 2,766,462 units worth $19,327,510 . The most active insider traders include Clay Thorp, Venture Advisors Iv Sbic, L…, and Venture Advisors Iii, Llc H…. On average, Clearside Biomedical executives and independent directors trade stock every 20 days with the average trade being worth of $94,756. The most recent stock trade was executed by Charles A. Deignan on 15 March 2019, trading 10,000 units of CLSD stock currently worth $13,600.

What does Clearside Biomedical do?

Clearside Biomedical, Inc. is a clinical stage biopharmaceutical company, which engages in the development of drug therapies to treat blinding diseases of the eye. Its pipeline includes Suprachoroidal CLS-TA, Suprachoroidal, Suprachoroidal CLS-TA, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in May 2011 and is headquartered in Alpharetta, GA.

What does Clearside Biomedical’s logo look like?

Complete history of Christy Shaffer stock trades at Clearside Biomedical and G1 Therapeutics

Clearside Biomedical executives and stock owners

Clearside Biomedical executives and other stock owners filed with the SEC include:

  • Charles Deignan, Chief Financial Officer
  • Clay Thorp, Independent Director
  • William Humphries, Independent Director
  • Richard Croarkin, Independent Director
  • Jeffrey Edwards, Director
  • Thomas Ciulla, Chief Medical Officer
  • Lester Rodriguez, Vice President – Quality
  • Viral Kansara, Vice President – Discovery
  • Carol Hoang, Vice President – Medical Affairs
  • Thomas Crawford, Vice President – Supply Chain
  • Leslie Zacks, Chief Compliance Officer, General Counsel
  • George Lasezkay, Interim Chief Executive Officer, Director
  • Christy Shaffer, Chairman of the Board
  • Venture Advisors Iii, Llc H…,
  • Venture Advisors Iv Sbic, L…,
  • Venture Advisors Iii, Llc H…,
  • Evgeny Zaytsev, Director
  • Daniel H. White, President and CEO
  • Investments S.A.R.L.Rusnano…,
  • Derek Yoon, Director
  • Gerald D. Cagle, Director
  • Venture Advisors Iv Sbic, L…,
  • Glenn Noronha, Executive Vice President, R&D
  • Brion S. Raymond, Chief Commercial Officer